Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why
Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why
Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country's Health Ministry which undertook expert hearings on various aspects of the issue with a focus on the best ways to protect young people and consumers' health.
德国正在慢慢走向娱乐性大麻合法化正如政府试图在2022年底之前完成这一进程。最新的推动来自该国的卫生部就这一问题的各个方面举行了专家听证会重点是保护年轻人和消费者健康的最佳方式。
The move could be a major catalyst for the market, especially for cannabis companies such as Tilray Brands, Inc. (NASDAQ:TLRY), which has operations in Germany.
这一举措可能成为市场的主要催化剂，特别是对大麻公司来说，如Tilray Brands公司(纳斯达克：TLRY)，在德国有业务。
Cantor Fitzgerald's analyst Pablo Zuanic said in his recent note that the sentiment for the company's stock may improve going forward.
康托·菲茨杰拉德的分析师巴勃罗·祖阿尼克在他最近的笔记中说，对该公司股票的情绪可能会在未来有所改善。
"We expect sentiment for the stock to improve in the months ahead on the back of news flow from Germany on the legalization of recreational sales," Zuanic said.
祖阿尼克表示：“我们预计，在德国娱乐销售合法化的消息传出后，未来几个月人们对该股的信心将有所改善。”
The Analyst
《分析师》
Zuanic retained a Neutral rating on the company's stock with a price target of $5.75, down from $6.15.
祖阿尼奇维持对该公司股票的中性评级，目标价从6.15美元降至5.75美元。
The Thesis
这篇论文是
The company is poised to benefit from being one of only three cannabis licensed manufacturers in Germany.
该公司是作为德国仅有的三家获得许可的大麻制造商之一，该公司有望从中受益。
The Canadian cannabis giant finalized its first harvest of medical cannabis grown in Germany via its subsidiary Aphria RX GmbH in July 2021, several months following the merger with Aphria.
这家加拿大大麻巨头通过其子公司完成了其在德国种植的第一批医用大麻的收获Aphria RX GmbH2021年7月，也就是与Aphria合并几个月后。
The company is scheduled to report the fiscal fourth quarter at the end of July. Zuanic tweaked his sales estimates, lowering EBITDA assumptions and saying that Tilray has "become somewhat of a meme stock, in our opinion, with significant volatility to the heavy presence of retail investors."
该公司是计划在7月底公布第四财季。祖阿尼克微调了他的销售预期，下调了EBITDA假设，并表示Tilray已经在我们看来，这在某种程度上成为了一种迷因股票，由于散户投资者的大量存在，股票的波动性很大。"
Strategic Partnership With HEXO
与HEXO建立战略合作伙伴关系
In the meantime, it remains to be seen how the agreement with HEXO Corp. (NASDAQ:HEXO) will play out.
与此同时，还有待观察的是，与HEXO公司达成协议(纳斯达克：HEXO)都会发挥到最后。
Earlier this year, the Canadian cannabis giant entered into a strategic partnership with HEXO - a debt financing agreement - under which it agreed to acquire $211 million in senior secured convertible notes that HEXO originally issued to HT Investments MA LLC. In April, Tilray signed a definitive agreement to purchase 100% of the remaining US$193 million outstanding principal balance of the senior secured convertible note.
今年早些时候，加拿大大麻巨头与HEXO达成战略合作伙伴关系-债务融资协议-根据该协议，它同意收购HEXO最初向HT Investments MA LLC发行的2.11亿美元优先担保可转换票据。今年4月，Tilray签署了一项最终协议，将100%购买优先担保可转换票据剩余的1.93亿美元未偿还本金余额。
Last week, that deal was amended to address current stock market conditions and to reduce closing risk.
上个星期，那个对交易进行了修改，以应对当前的股市状况并降低成交风险。
Zuanic said recently that Tilray could benefit from "HEXO's travails," leveraging the current state of the markets and the crisis HEXO is facing to negotiate terms, spend less cash and eventually convert the debt in a 50% equity stake in the company.
祖阿尼克最近表示，Tilray可能会从《HEXO的阵痛》中受益，利用目前的市场状况和HEXO面临的危机，HEXO就条款进行谈判，减少现金支出，最终将债务转换为公司50%的股权。
TLRY Price Action
TLRY价格行动
Tilray's shares traded 0.2123% higher at $3.5876 per share at the time of writing on Firday.
Tilray‘s股价上涨0.2123%，至每股3.5876美元。当我在星期五写这篇文章的时候。
Benzinga photo. Source: Image from Shutterstock
本辛加的照片。图片来源：Shutterstock
译文内容由第三方软件翻译。